Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05757778 · ClinicalTrials.gov registry record · NA
Split Chest Breast Neurotization
A NA study of Breast Implant; Complications, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT05757778 is a NA study of Breast Implant; Complications that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 6 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05757778, a NA study of Breast Implant; Complications, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Several members of the scientific community have suggested that breast neurotization can help return nipple sensation to patients undergoing implant-based breast reconstruction. There has been no randomized controlled study assessing the validity of these claims. The goal of this study is to evaluate if performing breast neurotization can help restore or improve return of nipple sensation to patients undergoing implant-based breast reconstruction. This will be a single-blinded, randomized controlled trial where patients undergoing bilateral reconstruction will serve as their own controls by receiving an intervention on one breast but not the other breast.
Conditions Studied
Interventions
- PROCEDURE Sensory Nerve Coaptation
Study Locations (1)
New York
- NYU Langone Health - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-08-08 |
| Est. Completion | 2027-04-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05757778
The ClinicalTrials.gov registry entry for NCT05757778 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Implant; Complications appearing as the primary indexed condition, and to 1 intervention - of which Sensory Nerve Coaptation is the first listed.
NCT05757778 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05757778 about?
NCT05757778 is a clinical study titled "Split Chest Breast Neurotization". Several members of the scientific community have suggested that breast neurotization can help return nipple sensation to patients undergoing implant-based breast reconstruction. There has been no randomized controlled study assessing the validity of these claims. The goal of this study is to evaluat...
What is the current status of trial NCT05757778?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 6 participants. The study started on 2023-08-08. Estimated completion is 2027-04-07.
What conditions does trial NCT05757778 study?
This clinical trial studies the following conditions: Breast Implant; Complications.
What interventions are being tested in trial NCT05757778?
The interventions under investigation include: Sensory Nerve Coaptation (PROCEDURE).
Who is sponsoring clinical trial NCT05757778?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05757778 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Implant; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.